[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Neuropace Inc (NPCE)

Neuropace Inc (NPCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 622,983
  • Shares Outstanding, K 33,950
  • Annual Sales, $ 99,990 K
  • Annual Income, $ -21,470 K
  • EBIT $ -16 M
  • EBITDA $ -14 M
  • 60-Month Beta 1.92
  • Price/Sales 6.55
  • Price/Cash Flow N/A
  • Price/Book 33.76

Options Overview Details

View History
  • Implied Volatility 93.75% (-9.08%)
  • Historical Volatility 47.51%
  • IV Percentile 20%
  • IV Rank 17.00%
  • IV High 247.30% on 11/14/25
  • IV Low 62.31% on 05/19/25
  • Expected Move (DTE 4) 2.47 (13.51%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 10
  • Volume Avg (30-Day) 27
  • Put/Call OI Ratio 0.46
  • Today's Open Interest 656
  • Open Int (30-Day) 513
  • Expected Range 15.79 to 20.72

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.19
  • Number of Estimates 3
  • High Estimate $-0.18
  • Low Estimate $-0.21
  • Prior Year $-0.21
  • Growth Rate Est. (year over year) +9.52%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.29 +24.63%
on 04/13/26
19.60 -9.13%
on 05/08/26
+3.55 (+24.89%)
since 04/10/26
3-Month
12.47 +42.82%
on 03/31/26
19.60 -9.13%
on 05/08/26
+3.25 (+22.32%)
since 02/11/26
52-Week
7.56 +135.50%
on 08/13/25
19.60 -9.13%
on 05/08/26
+4.92 (+38.17%)
since 05/09/25

Most Recent Stories

More News
NeuroPace to Report First Quarter 2026 Financial Results on May 12, 2026

NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will report financial results for the first quarter of 2026...

NPCE : 17.74 (-3.32%)
NeuroPace Highlights Expanding Clinical Evidence Leadership with Published 3-Year Post-Approval Study (PAS) Results in Neurology and NAUTILUS Presentation at AAN 2026

— Published 3-year Post-Approval Study results show 82% median seizure reduction in drug-resistant focal epilepsy — — American...

NPCE : 17.74 (-3.32%)
NeuroPace to Present at the 25th Annual Needham Virtual Healthcare Conference

NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its management team will present at the 25 th ...

NPCE : 17.74 (-3.32%)
NeuroPace to Present at the Leerink Global Healthcare Conference

NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its management team will present at the Leerink 2026 Global...

NPCE : 17.74 (-3.32%)
NeuroPace Inc.: Q4 Earnings Snapshot

NeuroPace Inc.: Q4 Earnings Snapshot

NPCE : 17.74 (-3.32%)
NeuroPace Reports Fourth Quarter and Full Year 2025 Financial Results and Reiterates 2026 Outlook

-- Reported quarterly revenue of $26.6 million in Q4 2025 representing 24% growth -- -- Reiterates previously issued 2026 guidance assuming 20% to 22% growth in core RNS...

NPCE : 17.74 (-3.32%)
NeuroPace to Report Fourth Quarter 2025 Financial Results on March 3, 2026

NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will report financial results for the fourth quarter of 2025...

NPCE : 17.74 (-3.32%)
NeuroPace Reports Preliminary Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook

-- Revenue expected to be approximately $100.0 million in FY 2025, representing growth of 25%-- --Revenue expected to be approximately $26.6 million in Q4 2025,...

NPCE : 17.74 (-3.32%)
NeuroPace to Present at the 44th Annual J.P. Morgan Healthcare Conference

NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its management team will present at the 44th Annual J.P....

NPCE : 17.74 (-3.32%)
NeuroPace Files PMA Supplement to FDA Seeking Expanded RNS® System Indication for Idiopathic Generalized Epilepsy

-- Submission supported by positive preliminary 18-month NAUTILUS data in patients with drug-resistant idiopathic generalized epilepsy (IGE) and generalized tonic-clonic (GTC) seizures --

NPCE : 17.74 (-3.32%)

Business Summary

NeuroPace Inc. is a commercial-stage medical device company. It is focused on developing products to treat and transform the lives of patients suffering from epilepsy. NeuroPace Inc. is based in MOUNTAIN VIEW, Calif.

See More

Key Turning Points

3rd Resistance Point 20.47
2nd Resistance Point 20.04
1st Resistance Point 19.19
Last Price 17.74
1st Support Level 17.91
2nd Support Level 17.48
3rd Support Level 16.63

See More

52-Week High 19.60
Last Price 17.74
Fibonacci 61.8% 15.00
Fibonacci 50% 13.58
Fibonacci 38.2% 12.16
52-Week Low 7.56

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.